Zivo Bioscience, Inc.
ZIVOOTCCIK 1101026HealthcareFiscal year ends Dec 31
Latest reported revenue, Q3 FY2025$65.6kRevenue, Q3 FY2025, three months to 2025-09-30$65.6k. XBRL concept
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-14, accession 0001654954-25-013095.Report this figureThree months to Sep 30, 2025, from the 10-Q filed Nov 14, 2025.Latest quarter: Q3 FY2025
Three months to Sep 30, 2025, against the same quarter a year earlier.
- Revenue$65.6kRevenue, Q3 FY2025, three months to 2025-09-30$65.6k. XBRL concept
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-14, accession 0001654954-25-013095.Report this figure+108.3% on a year earlier - Gross margin32.4%Gross margin, Q3 FY2025, three months to 2025-09-30. gross profit / revenueGross profit: $21.3k. XBRL concept
us-gaap:GrossProfit. 10-Q filed 2025-11-14, accession 0001654954-25-013095.Revenue: $65.6k. XBRL conceptus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-14, accession 0001654954-25-013095.Report this figure+2.4 pts on a year earlier - Operating margin−1551.8%Operating margin, Q3 FY2025, three months to 2025-09-30. operating income / revenueOperating income: −$1.0m. XBRL concept
us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-14, accession 0001654954-25-013095.Revenue: $65.6k. XBRL conceptus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-14, accession 0001654954-25-013095.Report this figure+5623.0 pts on a year earlier - Net margin−1574.2%Net margin, Q3 FY2025, three months to 2025-09-30. net income / revenueNet income: −$1.0m. XBRL concept
us-gaap:NetIncomeLoss. 10-Q filed 2025-11-14, accession 0001654954-25-013095.Revenue: $65.6k. XBRL conceptus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-14, accession 0001654954-25-013095.Report this figure+5627.7 pts on a year earlier - Diluted EPS−$0.27Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.27 per share. XBRL concept
us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-14, accession 0001654954-25-013095.Report this figure+59.7% on a year earlier - Free cash flownot reported (Capital expenditure not reported)No year-earlier figure to compare
Last eight quarters
Full statements| Line item | Unit | Q4 FY20232023-12-31 | Q1 FY20242024-03-31 | Q2 FY20242024-06-30 | Q3 FY20242024-09-30 | Q4 FY20242024-12-31 | Q1 FY20252025-03-31 | Q2 FY20252025-06-30 | Q3 FY20252025-09-30 | Shape over the periods |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $k | 11.8Revenue, Q4 FY2023, three months to 2023-12-31$11.8k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-03-18, accession 0001654954-25-002948. Derived: 12-month figure less the 9-month figure.Report this figure | 35.7Revenue, Q1 FY2024, three months to 2024-03-31$35.7k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-05-15, accession 0001654954-25-005748.Report this figure | 0.0Revenue, Q2 FY2024, three months to 2024-06-30$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-08-14, accession 0001654954-25-009650.Report this figure | 31.5Revenue, Q3 FY2024, three months to 2024-09-30$31.5k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-14, accession 0001654954-25-013095.Report this figure | 90.0Revenue, Q4 FY2024, three months to 2024-12-31$90.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-03-18, accession 0001654954-25-002948. Derived: 12-month figure less the 9-month figure.Report this figure | 0.0Revenue, Q1 FY2025, three months to 2025-03-31$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-05-15, accession 0001654954-25-005748.Report this figure | 53.4Revenue, Q2 FY2025, three months to 2025-06-30$53.4k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-08-14, accession 0001654954-25-009650.Report this figure | 65.6Revenue, Q3 FY2025, three months to 2025-09-30$65.6k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-14, accession 0001654954-25-013095.Report this figure | |
| Gross margin | % | 35.0%Gross margin, Q4 FY2023, three months to 2023-12-31. gross profit / revenueGross profit: $4.1k. XBRL concept us-gaap:GrossProfit. 10-K filed 2025-03-18, accession 0001654954-25-002948. Derived: 12-month figure less the 9-month figure.Revenue: $11.8k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-03-18, accession 0001654954-25-002948. Derived: 12-month figure less the 9-month figure.Report this figure | 35.0%Gross margin, Q1 FY2024, three months to 2024-03-31. gross profit / revenueGross profit: $12.5k. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-05-15, accession 0001654954-25-005748.Revenue: $35.7k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-05-15, accession 0001654954-25-005748.Report this figure | not reported (Revenue of zero not reported) | 30.0%Gross margin, Q3 FY2024, three months to 2024-09-30. gross profit / revenueGross profit: $9.4k. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-14, accession 0001654954-25-013095.Revenue: $31.5k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-14, accession 0001654954-25-013095.Report this figure | 30.0%Gross margin, Q4 FY2024, three months to 2024-12-31. gross profit / revenueGross profit: $27.0k. XBRL concept us-gaap:GrossProfit. 10-K filed 2025-03-18, accession 0001654954-25-002948. Derived: 12-month figure less the 9-month figure.Revenue: $90.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-03-18, accession 0001654954-25-002948. Derived: 12-month figure less the 9-month figure.Report this figure | not reported (Revenue of zero not reported) | 33.6%Gross margin, Q2 FY2025, three months to 2025-06-30. gross profit / revenueGross profit: $17.9k. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-08-14, accession 0001654954-25-009650.Revenue: $53.4k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-08-14, accession 0001654954-25-009650.Report this figure | 32.4%Gross margin, Q3 FY2025, three months to 2025-09-30. gross profit / revenueGross profit: $21.3k. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-14, accession 0001654954-25-013095.Revenue: $65.6k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-14, accession 0001654954-25-013095.Report this figure | |
| Operating margin | % | (16072.8%)Operating margin, Q4 FY2023, three months to 2023-12-31. operating income / revenueOperating income: −$1.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-18, accession 0001654954-25-002948. Derived: 12-month figure less the 9-month figure.Revenue: $11.8k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-03-18, accession 0001654954-25-002948. Derived: 12-month figure less the 9-month figure.Report this figure | (3571.8%)Operating margin, Q1 FY2024, three months to 2024-03-31. operating income / revenueOperating income: −$1.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-15, accession 0001654954-25-005748.Revenue: $35.7k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-05-15, accession 0001654954-25-005748.Report this figure | not reported (Revenue of zero not reported) | (7174.7%)Operating margin, Q3 FY2024, three months to 2024-09-30. operating income / revenueOperating income: −$2.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-14, accession 0001654954-25-013095.Revenue: $31.5k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-14, accession 0001654954-25-013095.Report this figure | (1773.8%)Operating margin, Q4 FY2024, three months to 2024-12-31. operating income / revenueOperating income: −$1.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-18, accession 0001654954-25-002948. Derived: 12-month figure less the 9-month figure.Revenue: $90.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-03-18, accession 0001654954-25-002948. Derived: 12-month figure less the 9-month figure.Report this figure | not reported (Revenue of zero not reported) | (3057.8%)Operating margin, Q2 FY2025, three months to 2025-06-30. operating income / revenueOperating income: −$1.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-14, accession 0001654954-25-009650.Revenue: $53.4k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-08-14, accession 0001654954-25-009650.Report this figure | (1551.8%)Operating margin, Q3 FY2025, three months to 2025-09-30. operating income / revenueOperating income: −$1.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-14, accession 0001654954-25-013095.Revenue: $65.6k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-14, accession 0001654954-25-013095.Report this figure | |
| Net margin | % | (16174.1%)Net margin, Q4 FY2023, three months to 2023-12-31. net income / revenueNet income: −$1.9m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-18, accession 0001654954-25-002948. Derived: 12-month figure less the 9-month figure.Revenue: $11.8k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-03-18, accession 0001654954-25-002948. Derived: 12-month figure less the 9-month figure.Report this figure | (3579.2%)Net margin, Q1 FY2024, three months to 2024-03-31. net income / revenueNet income: −$1.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-05-15, accession 0001654954-25-005748.Revenue: $35.7k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-05-15, accession 0001654954-25-005748.Report this figure | not reported (Revenue of zero not reported) | (7201.9%)Net margin, Q3 FY2024, three months to 2024-09-30. net income / revenueNet income: −$2.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-14, accession 0001654954-25-013095.Revenue: $31.5k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-14, accession 0001654954-25-013095.Report this figure | (1779.3%)Net margin, Q4 FY2024, three months to 2024-12-31. net income / revenueNet income: −$1.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-18, accession 0001654954-25-002948. Derived: 12-month figure less the 9-month figure.Revenue: $90.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-03-18, accession 0001654954-25-002948. Derived: 12-month figure less the 9-month figure.Report this figure | not reported (Revenue of zero not reported) | (3071.6%)Net margin, Q2 FY2025, three months to 2025-06-30. net income / revenueNet income: −$1.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-08-14, accession 0001654954-25-009650.Revenue: $53.4k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-08-14, accession 0001654954-25-009650.Report this figure | (1574.2%)Net margin, Q3 FY2025, three months to 2025-09-30. net income / revenueNet income: −$1.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-14, accession 0001654954-25-013095.Revenue: $65.6k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-14, accession 0001654954-25-013095.Report this figure | |
| Diluted EPS | $ per share | not reported (Diluted EPS not reported) | (0.47)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.47 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-15, accession 0001654954-25-005748.Report this figure | (2.78)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$2.78 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-14, accession 0001654954-25-009650.Report this figure | (0.67)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.67 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-14, accession 0001654954-25-013095.Report this figure | not reported (Diluted EPS not reported) | (1.12)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$1.12 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-15, accession 0001654954-25-005748.Report this figure | (0.43)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.43 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-14, accession 0001654954-25-009650.Report this figure | (0.27)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.27 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-14, accession 0001654954-25-013095.Report this figure | |
| Free cash flow | $k | not reported (Capital expenditure not reported) | not reported (Capital expenditure not reported) | not reported (Capital expenditure not reported) | not reported (Capital expenditure not reported) | not reported (Capital expenditure not reported) | not reported (Capital expenditure not reported) | not reported (Capital expenditure not reported) | not reported (Capital expenditure not reported) |
Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.
Last five fiscal years
| Line item | Unit | FY20202020-12-31 | FY20212021-12-31 | FY20222022-12-31 | FY20232023-12-31 | FY20242024-12-31 | Shape over the periods |
|---|---|---|---|---|---|---|---|
| Revenue | $k | 20.0Revenue, FY2020, twelve months to 2020-12-31$20.0k. XBRL concept us-gaap:Revenues. 10-K filed 2022-04-22, accession 0001654954-22-005298.Report this figure | 0.0Revenue, FY2021, twelve months to 2021-12-31$0. XBRL concept us-gaap:Revenues. 10-K filed 2023-03-14, accession 0001654954-23-002845.Report this figure | 0.0Revenue, FY2022, twelve months to 2022-12-31$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-03-15, accession 0001654954-24-003228.Report this figure | 27.7Revenue, FY2023, twelve months to 2023-12-31$27.6k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-03-18, accession 0001654954-25-002948.Report this figure | 157Revenue, FY2024, twelve months to 2024-12-31$157.2k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-03-18, accession 0001654954-25-002948.Report this figure | |
| Gross margin | % | not reported (Gross profit not reported) | not reported (Gross profit not reported) | not reported (Revenue of zero not reported) | 42.0%Gross margin, FY2023, twelve months to 2023-12-31. gross profit / revenueGross profit: $11.6k. XBRL concept us-gaap:GrossProfit. 10-K filed 2025-03-18, accession 0001654954-25-002948.Revenue: $27.6k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-03-18, accession 0001654954-25-002948.Report this figure | 31.1%Gross margin, FY2024, twelve months to 2024-12-31. gross profit / revenueGross profit: $49.0k. XBRL concept us-gaap:GrossProfit. 10-K filed 2025-03-18, accession 0001654954-25-002948.Revenue: $157.2k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-03-18, accession 0001654954-25-002948.Report this figure | |
| Operating margin | % | (42778.4%)Operating margin, FY2020, twelve months to 2020-12-31. operating income / revenueOperating income: −$8.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2022-04-22, accession 0001654954-22-005298.Revenue: $20.0k. XBRL concept us-gaap:Revenues. 10-K filed 2022-04-22, accession 0001654954-22-005298.Report this figure | not reported (Revenue of zero not reported) | not reported (Revenue of zero not reported) | (26267.7%)Operating margin, FY2023, twelve months to 2023-12-31. operating income / revenueOperating income: −$7.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-18, accession 0001654954-25-002948.Revenue: $27.6k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-03-18, accession 0001654954-25-002948.Report this figure | (8498.9%)Operating margin, FY2024, twelve months to 2024-12-31. operating income / revenueOperating income: −$13.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-18, accession 0001654954-25-002948.Revenue: $157.2k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-03-18, accession 0001654954-25-002948.Report this figure | |
| Net margin | % | (45528.6%)Net margin, FY2020, twelve months to 2020-12-31. net income / revenueNet income: −$9.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2022-04-22, accession 0001654954-22-005298.Revenue: $20.0k. XBRL concept us-gaap:Revenues. 10-K filed 2022-04-22, accession 0001654954-22-005298.Report this figure | not reported (Revenue of zero not reported) | not reported (Revenue of zero not reported) | (28127.2%)Net margin, FY2023, twelve months to 2023-12-31. net income / revenueNet income: −$7.8m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-18, accession 0001654954-25-002948.Revenue: $27.6k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-03-18, accession 0001654954-25-002948.Report this figure | (8513.4%)Net margin, FY2024, twelve months to 2024-12-31. net income / revenueNet income: −$13.4m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-18, accession 0001654954-25-002948.Revenue: $157.2k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-03-18, accession 0001654954-25-002948.Report this figure | |
| Diluted EPS | $ per share | (0.02)Diluted EPS, FY2020, twelve months to 2020-12-31−$0.02 per share. XBRL concept us-gaap:EarningsPerShareBasicAndDiluted. 10-K filed 2021-02-25, accession 0001078782-21-000172.Report this figure | not reported (Diluted EPS not reported) | not reported (Diluted EPS not reported) | (4.60)Diluted EPS, FY2023, twelve months to 2023-12-31−$4.60 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2025-03-18, accession 0001654954-25-002948.Report this figure | (4.23)Diluted EPS, FY2024, twelve months to 2024-12-31−$4.23 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2025-03-18, accession 0001654954-25-002948.Report this figure | |
| Free cash flow | $k | not reported (Capital expenditure not reported) | not reported (Capital expenditure not reported) | not reported (Capital expenditure not reported) | not reported (Capital expenditure not reported) | not reported (Capital expenditure not reported) |
Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.
Insider purchases and sales
All insider transactionsThe last 20 open-market transactions reported on Form 4 (codes P and S). The reported price is the price per share the insider stated on the form: filing data, not a market price.
No open-market purchases or sales by insiders are in coverage from Nov 2024 to Oct 2026.
No open-market purchases or sales by insiders are in coverage for this company.
Funds that report holding it
All fundsFrom each manager's latest Form 13F, largest reported value first. Reported value is as filed at the quarter end: filing data, not a price. A put or call is an option position, not shares held.
| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
|---|---|---|---|---|---|
| CoreCap Advisors, LLC | 2026-06-30 | $17.6k | 4,360 | Unchanged |
Recent filings
All 618 filingsReports and events: 10-K, 10-Q, 8-K, proxy statements and ownership schedules.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-03-3008:01 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001654954-26-002928 |
| 2026-02-2720:20 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001213900-26-021894 |
| 2025-12-2316:06 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001654954-25-014296 |
| 2025-11-1416:39 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001654954-25-013095 |
| 2025-09-1009:49 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001654954-25-010579 |
| 2025-08-1816:12 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001654954-25-009772 |
| 2025-08-1416:21 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001654954-25-009650 |
| 2025-07-1416:59 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001654954-25-008035 |
| 2025-06-1116:10 ET | 8-K | 5.07 Shareholder vote results | 0001654954-25-006837 |
| 2025-05-1516:10 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001654954-25-005748 |
Latest annual report
Form 10-K for the fiscal year ended Dec 31, 2024Filed Mar 18, 2025. Its page lists the documents and the extracted sections, such as Business and Risk factors.
Forecast league
Not in this season’s league. The league lists companies whose quarter has ended and whose results are not yet filed.This season’s league
About the filer
- CIK
- 1101026
- Tickers
- ZIVO
- Exchange
- OTC
- SIC code
- 2836 Biological Products, (No Diagnostic Substances)
- Sector
- Healthcare
- Fiscal year ends
- Dec 31
- Incorporated in
- NV
- Filer category
- Non-accelerated filer<br>Smaller reporting company
- Former names
- HEALTH ENHANCEMENT PRODUCTS INC (to 2014-10-16); WESTERN GLORY HOLE INC (to 2004-01-26)
Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:33 ET. Listed shows no prices and gives no investment advice.